More Protection for our Sons!

At yesterday’s meeting of the Advisory Committee on Immunization Practices at the Centers for Disease Control, it was recommended that that the HPV4 vaccine be routinely given to males aged 11-12 years with the 3-dose series.  The vaccination series can be started beginning at age 9 years.  In addition, vaccination is recommended for males aged 13-21 years who have not been vaccinated previously or who have not completed the 3-dose series.  Males aged 22 through 26 years may be vaccinated.  Priority should be given to males aged <22 years as vaccination of young men and boys would provide the greatest benefit.  This has the potential to prevent cancer in our boys later on, and is good news.